Induction of nitric oxide production by the peritoneal macrophages after intraperitoneal or subcutaneous transplantation of AK-5 tumor

Nitric Oxide - Biology and Chemistry

Volumn 2, Issue 6, 1998, Pages 467-474

  Bhaumik, Sraboni ^a   Khar, Ashok ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Macrophage; Nitric oxide; Tumor regression

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER TRANSPLANTATION; COCULTURE; CONTROLLED STUDY; CYTOLYSIS; HISTIOCYTOMA; MACROPHAGE ACTIVATION; NONHUMAN; PERITONEUM MACROPHAGE; PERITONEUM TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBCUTANEOUS TISSUE TUMOR; TUMOR CELL LINE;

ANIMALIA;

EID: 0032421884     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1006/niox.1998.0199     Document Type: Article

References (37)

1. MacMicking J., Xie Q-W., Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:1997;323-350.
2. Rodomski M. W. Nitric oxide: Biological mediator, modulator and effector. Ann. Med. 27:1995;321-329.
3. Weinberg E. D. Role of iron in functions of activated macrophages. J. Nutr. Immunol. 1:1992;41-63.
4. Duerksen-Hughes P. J., Day D., Laster S. M., Zachariades N. A., Aquino L., Gooding L. R. Both tumor necrosis factor and nitric oxide participate in lysis of simian virus 40 transformed cells by activated macrophages. J. Immunol. 149:1992;2114-2122.
5. Cui S., Reichner J. S., Mateo R. B., Albina J. E. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res. 54:1994;2462-2467.
6. Marletta M. A., Yoon P. S., Lyengar R., Leaf C. D., Wishnok J. Macrophage oxidation ofL. Biochemistry. 27:1988;8706-8711.
7. Tayeh M. A., Marletta M. A. Macrophage oxidation ofL. J. Biol. Chem. 264:1989;19654-19658.
8. Stuehr D. J., Marletta M. A. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines or interferon-γ J. Immunol. 139:1987;518-525.
9. Drapier J. C., Wietzerbin J., Hibbs J. B. Jr. Interferon-γ and tumor necrosis factor induceL. Eur. J. Immunol. 18:1988;1587-1592.
10. Cunha F. Q., Assreuy J., Moss D. W., Rees D., Leal L. M., Moncada S., Carrier M., O'Donnell C. A., Liew F. Y. Differential induction of nitric oxide synthase in various organs of the mouse during endotoxinemea: Role of TNF-α and IL-1β Immunology. 81:1994;211-215.
11. Stuehr D. J., Nathan C. F. Nitric oxide: A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1989;1543-1555.
12. Cox G., Melillo G., Chattopadhyay U., Mullet D., Fertel R. H., Varesio L. Tumor necrosis factor-α-dependent production of reactive nitrogen intermediates mediate IFN-γ plus IL-2 induced murine macrophage tumoricidal activity. J. Immunol. 149:1992;3290-3296.
13. Nicotera P., Brune B., Bagetta G. Nitric oxide: Inducer or suppressor of apoptosis? Trends Pharm. Sci. 18:1997;189-190.
14. Mantovani A., Bottazzi B., Colotta R., Sozzani S., Ruco L. Origin and function of tumor-associated macrophages. Immunol. Today. 13:1992;265-270.
15. DiNapoli M. R., Calderon C. L., Lopez D. M. The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduced expression of the inducible nitric oxide synthase gene. J. Exp. Med. 183:1996;1323-1329.
16. Alleva D. G., Burger G. J., Elgert K. D. Tumor induced regulation of suppressor-macrophage nitric oxide and TNF-α production: Role of tumor derived IL-10, TGF-β and prostaglandin. J. Immunol. 153:1994;1674-1686.
17. Calderon C. H., Huang Z. H., Gage D. A., Sotomayor E. M., Lopez D. M. Isolation of a nitric oxide inhibitor from mammary tumor cells and its characterisation as phosphatidyl serine. J. Exp. Med. 180:1994;945-958.
18. Khar A. Development and characterisation of a rat histiocyte-macrophage tumor line. J. Natl. Cancer Inst. 76:1986;871-878.
19. Bright J. J., Hegde S. P., Begum Z., Khar A. Modulation of natural killer cell function leading to spontaneous regression of a histocytoma. Cell. Immunol. 154:1994;54-65.
20. Khar A., Kumari A. L., Ali A. M. Characterisation of spontaneous immunological regression in histiocytoma: Participation of tumor necrosis factor. Int. J. Oncol. 2:1993;399-402.
21. Kausalya S., Hegde S. P., Bright J. J., Khar A. Mechanism of antibody-dependent natural killer cell mediated AK-5 tumor cell death. Exp. Cell Res. 212:1994;285-290.
22. Khar A., Pardhasaradhi B. V. V., Varalakshmi Ch., Ali A. M., Kumari A. L. Natural killer cell as the effector which mediates in vivo apoptosis in AK-5 tumor cells. Cell. Immunol. 177:1997;86-92.
23. Khar A., Kausalya S., Kamal M. A. AK-5 tumor induced modulation of host immune function: Upregulation of Th-1-type cytokine response mediates early tumor regression. Cytokines Mol. Ther. 2:1996;39-46.
24. Bhaumik S., Khar A. Cytokine induced production of NO by macrophages induces apoptosis and immunological rejection of AK-5 histiocytic tumor. Apoptosis. 1998.
25. Khar A., Ali A. M. Adaptation of rat histiocytoma cells AK-5, to growth in culture. In Vitro Cell. Dev. Biol. 26:1990;1024-1025.
26. Bhaumik S., Chattopadhyay S. Effect of shilajit on mouse peritoneal macrophages. Phytothera. Res. 7:1993;425-427.
27. Dietert R. R., Hotchkiss J. H., Austic R. E., Sung Y-J. Production of reactive nitrogen intermediates by macrophages. Methods Immunotoxicol. 2:1995;99-102.
28. Lewis J. G. State of macrophage activation: tumor cell cytolysis. Methods Immunotoxicol. 2:1995;59-65.
29. Laemmli U. K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
30. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
31. Adams D. O., Hamilton T. A. The cell biology of macrophage activation. Annu. Rev. Immunol. 2:1984;283-318.
32. Hibbs J. B. Jr, Taintor R. R., Vovrin Z., Rachlin E. M. Nitric oxide: A cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157:1989;87-94.
33. Lewis J. G., Adams D. O. The mononuclear phagocytic system and its interaction with xenobiotics. Immunology Toxicology and Immunopharmacology. 1985;Raven Press, New York. p. 23-44.
34. Moncada S., Palmer R. M. J., Higgs E. A. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142.
35. Ding A. H., Nathan C. F., Steuhr D. J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:1988;2407-2412.
36. Tamir S., Tannenbaum S. R. The role of nitric oxide (NO) in the carcinogenic process. Biochem. Biophys. Acta. 1288:1996;F31-F36.
37. Sotomayor E. M., Di Napoli M. R., Calderon C., Colsky A., Fu Y-X., Lopez D. M. Decreased macrophage mediated cytotoxicity in mammary-tumor-bearing mice is related to an alteration of nitric oxide production and/or release. Int. J. Cancer. 60:1995;660-667.